文献速递中医内科中药与中成药合理使用

登石清脉汤缓解PM2.5肺损伤机制:网络药理学、代谢组学与靶点验证

Mechanisms of Deng-Shi-Qing-Mai-Tang in alleviating PM2.5-Induced lung Injury: Network pharmacology, metabolomics, and molecular Target validation.
PubMed 文献 · J Ethnopharmacol · 2025-04-30

该研究结合网络药理学、代谢组学与实验验证,探讨登石清脉汤(DSQMT)缓解PM2.5诱导肺损伤的机制。芦丁与桑辛素分别靶向ALOX15与NOS2,验证了抗氧化与抗炎作用。

要点

  • DSQMT可降低PM2.5诱导的ROS与MDA水平,提高SOD活性。
  • NOS2与ALOX15是DSQMT保护作用的核心分子靶点。
  • 芦丁与桑辛素分别调控ALOX15与NOS2表达,贡献抗炎抗氧化效应。

核心结论

  • DSQMT通过代谢调节与抗氧化活性缓解PM2.5诱导的肺损伤。
  • 芦丁与桑辛素靶向NOS2和ALOX15,为DSQMT的疗效提供机制解释。

研究设计与样本

  • 建立PM2.5诱导的大鼠肺损伤模型及PM2.5处理的NR8383细胞体外模型。
  • 采用网络药理学预测靶点与通路,代谢组学分析代谢变化,分子对接评估结合亲和力。
  • 通过组织学分析、细胞毒性检测及氧化应激标志物(ROS、MDA、SOD)评估疗效。
  • 用RT-qPCR和Western blot验证芦丁与桑辛素对NOS2和ALOX15表达的影响。

主要发现

  • DSQMT逆转PM2.5诱导的代谢紊乱,恢复关键通路稳态。
  • 分子对接显示桑辛素与NOS2、芦丁与ALOX15有强结合。
  • 体外实验显示DSQMT降低ROS和MDA水平、增加SOD活性,减轻氧化应激与细胞毒性。
  • RT-qPCR和Western blot证实芦丁与桑辛素调控NOS2和ALOX15表达。

临床怎么用

  • DSQMT可能作为PM2.5相关肺损伤的潜在治疗选择,尤其适用于污染相关呼吸道疾病管理。
  • 芦丁与桑辛素可作为质控或活性成分参考,用于DSQMT制剂的质量评价。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Deng-Shi-Qing-Mai-Tang (DSQMT) is a traditional Chinese herbal formula known for treating inflammatory diseases, particularly those affecting respiratory health. Urban air pollution, especially fine particulate matter (PM2.5), induces lung injury primarily through inflammation and oxidative stress. DSQMT's potential to mitigate PM2.5-induced lung damage makes it a promising ethnopharmacological candidate for pollution-related pulmonary disorders. AIM OF THE STUDY: This study aims to uncover the therapeutic mechanisms of DSQMT in alleviating PM2.5-induced lung injury, focusing on identifying its active compounds and their molecular targets. By integrating network pharmacology, metabolomics, and experimental validation, we provide a comprehensive understanding of DSQMT's mode of action. MATERIALS AND METHODS: We established a rat model of PM2.5-induced lung injury and an in vitro model using PM2.5-treated NR8383 cells. Network pharmacology was applied to predict molecular targets and associated biological pathways affected by DSQMT. Metabolomic profiling identified key metabolic changes, and a pharmacological-metabolomic network was constructed. Molecular docking assessed by binding affinities between DSQMT's active compounds and their targets. The therapeutic effects of DSQMT were evaluated using histological analysis, cytotoxicity assays, and oxidative stress markers, including reactive oxygen species (ROS), malondialdehyde (MDA), and superoxide dismutase (SOD). Additionally, the roles of Rutin and Morusin, two bioactive compounds, were further validated through RT-qPCR and Western blot to determine their effects on NOS2 and ALOX15 expression. RESULTS: DSQMT treatment reversed PM2.5-induced metabolic disturbances, restoring homeostasis in key pathways. We identified fifty-one therapeutic targets and fifty metabolites, with NOS2 and ALOX15 emerging as central to DSQMT's protective effects. Molecular docking revealed strong binding between Morusin and NOS2, as well as Rutin and ALOX15. In vitro experiments showed that DSQMT reduced oxidative stress and cytotoxicity, as evidenced by decreased ROS and MDA levels and increased SOD activity. RT-qPCR and Western blot confirmed that Rutin and Morusin modulated NOS2 and ALOX15 expression, validating their contributions to DSQMT's anti-inflammatory and antioxidant effects. CONCLUSIONS: DSQMT alleviates PM2.5-induced lung injury through metabolic regulation and antioxidant activity. The identification of Rutin and Morusin as key compounds targeting NOS2 and ALOX15 provides mechanistic insights into DSQMT's therapeutic effects. These findings support DSQMT as a potential treatment for PM2.5-related lung injury, highlighting its relevance in managing pollution-induced respiratory diseases.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Zhou Y, Wen C, Huang Y, et al. Mechanisms of Deng-Shi-Qing-Mai-Tang in alleviating PM2.5-Induced lung Injury: Network pharmacology, metabolomics, and molecular Target validation. J Ethnopharmacol. 2025. PMID: 40316151. doi:10.1016/j.jep.2025.119910

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。